Goldman Sachs Group Inc. announced McKesson Corporation (NYSE:MCK), dropping its stock price target to $189.00 today
- Updated: September 15, 2016
Having a price of $168.97, McKesson Corporation (NYSE:MCK) traded 1.44% lower on the day. The last stock price is down 6.67% relative to the 200-day moving average, compared with the Standard & Poor’s 500 Index which has fallen -0.01% over the same period. MCK has been tracking to a 50-day moving average of $188.37 and 200-day moving average of $178.44. Trade volume was was down over the average, with 500,883 shares of MCK changing hands under the typical 1,390,240 shares.
In an issued report on 9/16/2016 Goldman Sachs Group Inc. reduced the target price of McKesson Corporation (NYSE:MCK) from $210 to $189 indicating a possible upsideof 0.12%.
Previously on 8/11/2016, Mizuho Securities released a statement about McKesson Corporation(NYSE:MCK) bumped the target price from $174.00 to $197.00. At the time, this suggested an upside of 0.01%.
A total of 15 analysts have reported on MCK. Four firms rate the stock a strong buy, seven analysts rate the company a buy, seven analyts rate the stock a hold, 0 rate the company to underperform, and lastly 0 firmsrate the company as sell with an average target price of $195.93
McKesson Corporation has a 52 week low of $148.29 and a one-year high of $208.03 with a PE ratio of 17 and has a total market value of $0.0.
Brief Synopsis About McKesson Corporation (NYSE:MCK)
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, and which is a payment technology.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.